AB Science S.A. A8D.F Stock
AB Science S.A. Price Chart
AB Science S.A. A8D.F Financial and Trading Overview
| AB Science S.A. stock price | 2.16 EUR |
| Previous Close | 4.85 EUR |
| Open | 4.74 EUR |
| Bid | 4.76 EUR x 23800 |
| Ask | 4.81 EUR x 23500 |
| Day's Range | 4.74 - 4.74 EUR |
| 52 Week Range | 4.05 - 9.17 EUR |
| Volume | 140 EUR |
| Avg. Volume | 10 EUR |
| Market Cap | 250.95M EUR |
| Beta (5Y Monthly) | 0.881992 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.36 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
A8D.F Valuation Measures
| Enterprise Value | 246.64M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 261.94684 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 257.455 |
| Enterprise Value/EBITDA | -15.884 |
Trading Information
AB Science S.A. Stock Price History
| Beta (5Y Monthly) | 0.881992 |
| 52-Week Change | -49.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.17 EUR |
| 52 Week Low | 4.05 EUR |
| 50-Day Moving Average | 5.33 EUR |
| 200-Day Moving Average | 6.89 EUR |
A8D.F Share Statistics
| Avg. Volume (3 month) | 10 EUR |
| Avg. Daily Volume (10-Days) | 32 EUR |
| Shares Outstanding | 46.89M |
| Float | 27.3M |
| Short Ratio | N/A |
| % Held by Insiders | 41.25% |
| % Held by Institutions | 1.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1663.67% |
| Gross Margin | 96.76% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.16% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 958K EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | -58.29% |
| Gross Profit (ttm) | 927K EUR |
| EBITDA | -15528000 EUR |
| Net Income Avi to Common (ttm) | -13615000 EUR |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.27M EUR |
| Total Cash Per Share (mrq) | 0.16 EUR |
| Total Debt (mrq) | 27.74M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.904 |
| Book Value Per Share (mrq) | -0.765 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17471000 EUR |
| Levered Free Cash Flow (ttm) | -12785625 EUR |
Profile of AB Science S.A.
| Country | Germany |
| State | N/A |
| City | Paris |
| Address | 3, avenue George V |
| ZIP | 75008 |
| Phone | 33 1 47 20 00 14 |
| Website | https://www.ab-science.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 103 |
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Q&A For AB Science S.A. Stock
What is a current A8D.F stock price?
AB Science S.A. A8D.F stock price today per share is 2.16 EUR.
How to purchase AB Science S.A. stock?
You can buy A8D.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AB Science S.A.?
The stock symbol or ticker of AB Science S.A. is A8D.F.
Which industry does the AB Science S.A. company belong to?
The AB Science S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does AB Science S.A. have in circulation?
The max supply of AB Science S.A. shares is 51.37M.
What is AB Science S.A. Price to Earnings Ratio (PE Ratio)?
AB Science S.A. PE Ratio is now.
What was AB Science S.A. earnings per share over the trailing 12 months (TTM)?
AB Science S.A. EPS is -0.36 EUR over the trailing 12 months.
Which sector does the AB Science S.A. company belong to?
The AB Science S.A. sector is Healthcare.